** Shares of retail pharmacy franchisor Sigma Healthcare SIG.AX up 2.7% at A$3.1, their highest since February 17
** Morgan Stanley starts with "Overweight" and PT of A$3.45
** Cites defensive earnings and sales growth on sector consolidation, cost, and revenue synergies
** Expects over 20% EBIT/EPS VAGR from FY25-28
** Adds, SIG's merger with Chemist Warehouse offers significant and potentially understated synergies from supply chain efficiencies and improved store productivity
** Stock up 17.8% YTD
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))